Pathway
|
Identified node
|
p-value
|
q-value
|
BioCarta//Hs_Toll-Like Receptor Pathway
|
4/34 (45)
|
0.5214
|
0.1311
|
BioCarta//Hs_Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)
|
10/54 (64)
|
0.0632
|
0.1311
|
BioCarta//Hs_FAS signaling pathway ( CD95 )
|
3/30 (34)
|
0.6555
|
0.1311
|
BioCarta//Hs_HIV-I Nef: negative effector of Fas and TNF
|
8/57 (77)
|
0.2815
|
0.1311
|
BioCarta//Hs_Induction of apoptosis through DR3 and DR4/5 Death Receptors
|
5/32 (37)
|
0.2687
|
0.1311
|
BioCarta//Hs_Apoptotic Signaling in Response to DNA Damage
|
6/21 (29)
|
0.0211
|
0.1311
|
BioCarta//Hs_EGF Signaling Pathway
|
6/27 (54)
|
0.0664
|
0.1311
|
BioCarta//Hs_IL-10 Anti-inflammatory Signaling Pathway
|
2/13 (17)
|
0.4254
|
0.1311
|
BioCarta//Hs_MAPKinase Signaling Pathway
|
10/85 (88)
|
0.4569
|
0.1311
|
BioCarta//Hs_p38 MAPK Signaling Pathway
|
4/38 (40)
|
0.6131
|
0.1311
|
BioCarta//Hs_PDGF Signaling Pathway
|
7/27 (61)
|
0.0222
|
0.1311
|
BioCarta//Hs_TPO Signaling Pathway
|
6/23 (54)
|
0.0327
|
0.1311
|
BioCarta//Hs_Bioactive Peptide Induced Signaling Pathway
|
7/38 (58)
|
0.1135
|
0.1311
|
BioCarta//Hs_ER-associated degradation (ERAD) Pathway
|
1/13 (20)
|
0.7801
|
0.1311
|
BioCarta//Hs_Regulation of p27 Phosphorylation during Cell Cycle Progression
|
1/13 (20)
|
0.7801
|
0.1311
|
BioCarta//Hs_Selective expression of chemokine receptors during T-cell polarization
|
3/29 (55)
|
0.6320
|
0.1311
|
BioCarta//Hs_Agrin in Postsynaptic Differentiation
|
4/39 (50)
|
0.6342
|
0.1311
|
BioCarta//Hs_Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages
|
2/25 (42)
|
0.7784
|
0.1311
|
BioCarta//Hs_VEGF, Hypoxia, and Angiogenesis
|
6/28 (34)
|
0.0771
|
0.1311
|
BioCarta//Hs_Eicosanoid Metabolism
|
6/20 (20)
|
0.0166
|
0.1311
|
BioCarta//Hs_Aspirin Blocks Signaling Pathway Involved in Platelet Activation
|
6/22 (32)
|
0.0265
|
0.1311
|
BioCarta//Hs_Cytokines and Inflammatory Response
|
3/27 (78)
|
0.5819
|
0.1311
|
BioCarta//Hs_Hypoxia and p53 in the Cardiovascular system
|
5/22 (37)
|
0.0839
|
0.1311
|
BioCarta//Hs_NFAT and Hypertrophy of the heart (Transcription in the broken heart)
|
5/51 (82)
|
0.6740
|
0.1311
|
BioCarta//Hs_Regulation of BAD phosphorylation
|
4/22 (31)
|
0.2148
|
0.1311
|
BioCarta//Hs_Repression of Pain Sensation by the Transcriptional Regulator DREAM
|
3/14 (21)
|
0.1916
|
0.1311
|
BioCarta//Hs_Signaling Pathway from G-Protein Families
|
5/34 (42)
|
0.3134
|
0.1311
|
BioCarta//Hs_Stathmin and breast cancer resistance to antimicrotubule agents
|
4/23 (26)
|
0.2393
|
0.1311
|
BioCarta//Hs_Transcription factor CREB and its extracellular signals
|
4/26 (26)
|
0.3162
|
0.1311
|
BioCarta//Hs_Actions of Nitric Oxide in the Heart
|
6/30 (44)
|
0.1014
|
0.1311
|
BioCarta//Hs_IL-2 Receptor Beta Chain in T cell Activation
|
3/35 (38)
|
0.7567
|
0.1311
|
BioCarta//Hs_Deregulation of CDK5 in Alzheimers Disease
|
3/10 (16)
|
0.0870
|
0.1311
|
BioCarta//Hs_Integrin Signaling Pathway
|
5/37 (45)
|
0.3820
|
0.1311
|
BioCarta//Hs_Effects of calcineurin in Keratinocyte Differentiation
|
2/18 (36)
|
0.6034
|
0.1311
|
BioCarta//Hs_ATM Signaling Pathway
|
5/19 (32)
|
0.0484
|
0.1311
|
BioCarta//Hs_Intrinsic Prothrombin Activation Pathway
|
5/23 (36)
|
0.0981
|
0.1311
|
BioCarta//Hs_T Cell Receptor Signaling Pathway
|
5/43 (56)
|
0.5168
|
0.1311
|
BioCarta//Hs_Ahr Signal Transduction Pathway
|
2/4 (12)
|
0.0617
|
0.1311
|
BioCarta//Hs_Rho cell motility signaling pathway
|
4/30 (32)
|
0.4208
|
0.1311
|
BioCarta//Hs_Phospholipids as signalling intermediaries
|
4/25 (42)
|
0.2902
|
0.1311
|
BioCarta//Hs_Synaptic Proteins at the Synaptic Junction
|
3/20 (32)
|
0.3779
|
0.1311
|
BioCarta//Hs_fMLP induced chemokine gene expression in HMC-1 cells
|
3/36 (58)
|
0.7738
|
0.1311
|
BioCarta//Hs_Role of ?arrestins in the activation and targeting of MAP kinases
|
3/17 (40)
|
0.2833
|
0.1311
|
BioCarta//Hs_CCR3 signaling in Eosinophils
|
3/23 (30)
|
0.4698
|
0.1311
|
BioCarta//Hs_Cadmium induces DNA synthesis and proliferation in macrophages
|
4/15 (21)
|
0.0724
|
0.1311
|
BioCarta//Hs_Activation of PKC through G protein coupled receptor
|
2/7 (8)
|
0.1736
|
0.1311
|
BioCarta//Hs_Extrinsic Prothrombin Activation Pathway
|
3/13 (24)
|
0.1630
|
0.1311
|
BioCarta//Hs_Circadian Rhythms
|
3/6 (13)
|
0.0201
|
0.1311
|
BioCarta//Hs_Regulation of eIF4e and p70 S6 Kinase
|
3/24 (37)
|
0.4992
|
0.1311
|
BioCarta//Hs_IGF-1 Signaling Pathway
|
4/20 (45)
|
0.1681
|
0.1311
|
BioCarta//Hs_Signaling of Hepatocyte Growth Factor Receptor
|
5/36 (42)
|
0.3591
|
0.1311
|
BioCarta//Hs_Proteasome Complex
|
3/19 (24)
|
0.3464
|
0.1311
|
BioCarta//Hs_Map Kinase Inactivation of SMRT Corepressor
|
3/11 (14)
|
0.1103
|
0.1311
|
BioCarta//Hs_Biosynthesis of threonine and methionine
|
1/2 (2)
|
0.2072
|
0.1311
|
BioCarta//Hs_Feeder Pathways for Glycolysis
|
2/9 (11)
|
0.2583
|
0.1311
|
BioCarta//Hs_Ceramide Signaling Pathway
|
4/21 (21)
|
0.1910
|
0.1311
|
BioCarta//Hs_CXCR4 Signaling Pathway
|
2/24 (35)
|
0.7583
|
0.1311
|
BioCarta//Hs_EPO Signaling Pathway
|
2/19 (36)
|
0.6336
|
0.1311
|
BioCarta//Hs_Erk1/Erk2 Mapk Signaling pathway
|
5/28 (33)
|
0.1849
|
0.1311
|
BioCarta//Hs_Human Cytomegalovirus and Map Kinase Pathways
|
2/16 (17)
|
0.5374
|
0.1311
|
BioCarta//Hs_IL 2 signaling pathway
|
2/22 (47)
|
0.7135
|
0.1311
|
BioCarta//Hs_IL 6 signaling pathway
|
3/21 (48)
|
0.4091
|
0.1311
|
BioCarta//Hs_Keratinocyte Differentiation
|
4/46 (67)
|
0.7609
|
0.1311
|
BioCarta//Hs_Links between Pyk2 and Map Kinases
|
3/28 (44)
|
0.6075
|
0.1311
|
BioCarta//Hs_Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation
|
2/15 (29)
|
0.5018
|
0.1311
|
BioCarta//Hs_Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway
|
3/12 (16)
|
0.1358
|
0.1311
|
BioCarta//Hs_Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling
|
4/33 (44)
|
0.4969
|
0.1311
|
BioCarta//Hs_Regulation of PGC-1a
|
2/23 (31)
|
0.7367
|
0.1311
|
BioCarta//Hs_Role of MEF2D in T-cell Apoptosis
|
3/16 (45)
|
0.2521
|
0.1311
|
BioCarta//Hs_Nuclear Receptors in Lipid Metabolism and Toxicity
|
3/34 (43)
|
0.7385
|
0.1311
|
BioCarta//Hs_Small Leucine-rich Proteoglycan (SLRP) molecules
|
2/6 (6)
|
0.1333
|
0.1311
|
BioCarta//Hs_Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility
|
2/21 (25)
|
0.6886
|
0.1311
|
BioCarta//Hs_Fibrinolysis Pathway
|
2/11 (14)
|
0.3435
|
0.1311
|
BioCarta//Hs_Telomeres, Telomerase, Cellular Aging, and Immortality
|
3/18 (31)
|
0.3148
|
0.1311
|
BioCarta//Hs_Opposing roles of AIF in Apoptosis and Cell Survival
|
1/3 (8)
|
0.2942
|
0.1311
|
BioCarta//Hs_Hypoxia-Inducible Factor in the Cardiovascular System
|
3/15 (20)
|
0.2214
|
0.1311
|
BioCarta//Hs_Degradation of the RAR and RXR by the proteasome
|
2/3 (11)
|
0.0332
|
0.1311
|
BioCarta//Hs_FXR and LXR Regulation of Cholesterol Metabolism
|
2/8 (14)
|
0.2156
|
0.1311
|
BioCarta//Hs_Role of Ran in mitotic spindle regulation
|
1/10 (15)
|
0.6878
|
0.1311
|
BioCarta//Hs_Proepithelin Conversion to Epithelin and Wound Repair Control
|
1/6 (40)
|
0.5022
|
0.1311
|
BioCarta//Hs_Adhesion and Diapedesis of Lymphocytes
|
2/14 (47)
|
0.4644
|
0.1311
|
BioCarta//Hs_Monocyte and its Surface Molecules
|
1/11 (12)
|
0.7222
|
0.1311
|
BioCarta//Hs_The PRC2 Complex sets Long-term gene Silencing The Modification of Histone Tails
|
1/12 (20)
|
0.7529
|
0.1311
|
BioCarta//Hs_Trka Receptor Signaling Pathway
|
2/12 (12)
|
0.3850
|
0.1311
|
BioCarta//Hs_RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage
|
1/13 (17)
|
0.7801
|
0.1311
|
BioCarta//Hs_Regulation of cell cycle progression by Plk3
|
1/8 (17)
|
0.6057
|
0.1311
|
BioCarta//Hs_Mechanism of Protein Import into the Nucleus
|
1/9 (19)
|
0.6491
|
0.1311
|
BioCarta//Hs_Sumoylation by RanBP2 Regulates Transcriptional Repression
|
2/10 (25)
|
0.3011
|
0.1311
|
BioCarta//Hs_g-Secretase mediated ErbB4 Signaling Pathway
|
1/7 (19)
|
0.5569
|
0.1311
|
BioCarta//Hs_Oxidative Stress Induced Gene Expression Via Nrf2
|
2/20 (24)
|
0.6620
|
0.1311
|
BioCarta//Hs_Pertussis toxin-insensitive CCR5 Signaling in Macrophage
|
2/17 (38)
|
0.5713
|
0.1311
|
BioCarta//Hs_Phospholipase C d1 in phospholipid associated cell signaling
|
1/5 (10)
|
0.4407
|
0.1311
|
BioCarta//Hs_Transcriptional activation of dbpb from mRNA
|
1/4 (9)
|
0.3717
|
0.1311
|
BioCarta//Hs_IL12 and Stat4 Dependent Signaling Pathway in Th1 Development
|
2/21 (27)
|
0.6886
|
0.1312
|
BioCarta//Hs_Control of Gene Expression by Vitamin D Receptor
|
2/24 (32)
|
0.7583
|
0.1313
|
BioCarta//Hs_mTOR Signaling Pathway
|
2/24 (44)
|
0.7583
|
0.1313
|
BioCarta//Hs_Fc Epsilon Receptor I Signaling in Mast Cells
|
3/38 (49)
|
0.8050
|
0.1314
|
BioCarta//Hs_Growth Hormone Signaling Pathway
|
2/26 (35)
|
0.7969
|
0.1314
|
BioCarta//Hs_Bone Remodelling
|
1/14 (19)
|
0.8044
|
0.1314
|
BioCarta//Hs_Lectin Induced Complement Pathway
|
2/12 (56)
|
0.3850
|
0.1316
|
BioCarta//Hs_Cystic fibrosis transmembrane conductance regulator and beta 2 adrenergic receptor pathway
|
2/12 (37)
|
0.3850
|
0.1316
|
BioCarta//Hs_Rab GTPases Mark Targets In The Endocytotic Machinery
|
2/12 (17)
|
0.3850
|
0.1316
|
BioCarta//Hs_Role of Parkin in the Ubiquitin-Proteasomal Pathway
|
2/12 (38)
|
0.3850
|
0.1316
|
BioCarta//Hs_Spliceosomal Assembly
|
1/14 (14)
|
0.8044
|
0.1319
|
BioCarta//Hs_The IGF-1 Receptor and Longevity
|
1/14 (14)
|
0.8044
|
0.1319
|
BioCarta//Hs_Multi-step Regulation of Transcription by Pitx2
|
1/16 (38)
|
0.8453
|
0.1321
|
BioCarta//Hs_The Co-Stimulatory Signal During T-cell Activation
|
1/16 (40)
|
0.8453
|
0.1321
|
BioCarta//Hs_Downregulated of MTA-3 in ER-negative Breast Tumors
|
1/16 (23)
|
0.8453
|
0.1321
|
BioCarta//Hs_Steps in the Glycosylation of Mammalian N-linked Oligosaccarides
|
1/16 (16)
|
0.8453
|
0.1321
|
BioCarta//Hs_Acetylation and Deacetylation of RelA in The Nucleus
|
1/16 (34)
|
0.8453
|
0.1321
|
BioCarta//Hs_Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK)
|
2/28 (41)
|
0.8301
|
0.1321
|
BioCarta//Hs_IL-7 Signal Transduction
|
1/16 (29)
|
0.8453
|
0.1321
|
BioCarta//Hs_Adhesion and Diapedesis of Granulocytes
|
1/15 (49)
|
0.8260
|
0.1321
|
BioCarta//Hs_Chaperones modulate interferon Signaling Pathway
|
1/16 (34)
|
0.8453
|
0.1321
|
BioCarta//Hs_Eukaryotic protein translation
|
3/15 (20)
|
0.2214
|
0.1322
|
BioCarta//Hs_Regulation of hematopoiesis by cytokines
|
3/15 (41)
|
0.2214
|
0.1322
|
BioCarta//Hs_Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration
|
3/15 (15)
|
0.2214
|
0.1322
|
BioCarta//Hs_PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase
|
3/15 (18)
|
0.2214
|
0.1322
|
BioCarta//Hs_Glycolysis Pathway
|
1/10 (21)
|
0.6878
|
0.1323
|
BioCarta//Hs_Apoptotic DNA fragmentation and tissue homeostasis
|
1/10 (15)
|
0.6878
|
0.1323
|
BioCarta//Hs_E2F1 Destruction Pathway
|
1/10 (16)
|
0.6878
|
0.1323
|
BioCarta//Hs_Double Stranded RNA Induced Gene Expression
|
1/10 (14)
|
0.6878
|
0.1323
|
BioCarta//Hs_Eph Kinases and ephrins support platelet aggregation
|
1/10 (17)
|
0.6878
|
0.1323
|
BioCarta//Hs_SODD/TNFR1 Signaling Pathway
|
1/10 (18)
|
0.6878
|
0.1323
|
BioCarta//Hs_CARM1 and Regulation of the Estrogen Receptor
|
2/26 (33)
|
0.7969
|
0.1323
|
BioCarta//Hs_Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells
|
2/26 (43)
|
0.7969
|
0.1323
|
BioCarta//Hs_Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway
|
2/20 (23)
|
0.6620
|
0.1324
|
BioCarta//Hs_Acute Myocardial Infarction
|
2/20 (23)
|
0.6620
|
0.1324
|
BioCarta//Hs_IFN alpha signaling pathway
|
1/9 (25)
|
0.6491
|
0.1325
|
BioCarta//Hs_Cyclin E Destruction Pathway
|
1/9 (14)
|
0.6491
|
0.1325
|
BioCarta//Hs_Regulation of eIF2
|
1/9 (20)
|
0.6491
|
0.1325
|
BioCarta//Hs_Polyadenylation of mRNA
|
1/9 (35)
|
0.6491
|
0.1325
|
BioCarta//Hs_B Lymphocyte Cell Surface Molecules
|
1/9 (10)
|
0.6491
|
0.1325
|
BioCarta//Hs_Cardiac Protection Against ROS
|
1/9 (9)
|
0.6491
|
0.1325
|
BioCarta//Hs_Visual Signal Transduction
|
1/9 (12)
|
0.6491
|
0.1325
|
BioCarta//Hs_Signal Dependent Regulation of Myogenesis by Corepressor MITR
|
1/9 (25)
|
0.6491
|
0.1325
|
BioCarta//Hs_Adhesion Molecules on Lymphocyte
|
1/9 (10)
|
0.6491
|
0.1325
|
BioCarta//Hs_cdc25 and chk1 Regulatory Pathway in response to DNA damage
|
1/9 (13)
|
0.6491
|
0.1325
|
BioCarta//Hs_WNT Signaling Pathway
|
2/25 (42)
|
0.7784
|
0.1325
|
BioCarta//Hs_D4-GDI Signaling Pathway
|
1/12 (15)
|
0.7529
|
0.1327
|
BioCarta//Hs_CTL mediated immune response against target cells
|
1/12 (25)
|
0.7529
|
0.1327
|
BioCarta//Hs_Gamma-aminobutyric Acid Receptor Life Cycle
|
1/12 (73)
|
0.7529
|
0.1327
|
BioCarta//Hs_Ca++/ Calmodulin-dependent Protein Kinase Activation
|
1/12 (76)
|
0.7529
|
0.1327
|
BioCarta//Hs_IFN gamma signaling pathway
|
1/6 (28)
|
0.5022
|
0.1330
|
BioCarta//Hs_Pelp1 Modulation of Estrogen Receptor Activity
|
1/6 (10)
|
0.5022
|
0.1330
|
BioCarta//Hs_Visceral Fat Deposits and the Metabolic Syndrome
|
1/6 (9)
|
0.5022
|
0.1330
|
BioCarta//Hs_ALK in cardiac myocytes
|
3/34 (51)
|
0.7385
|
0.1331
|
BioCarta//Hs_BCR Signaling Pathway
|
3/34 (54)
|
0.7385
|
0.1331
|
BioCarta//Hs_beta-arrestins in GPCR Desensitization
|
1/15 (40)
|
0.8260
|
0.1332
|
BioCarta//Hs_Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to fa
|
1/15 (28)
|
0.8260
|
0.1332
|
BioCarta//Hs_Cyclins and Cell Cycle Regulation
|
3/23 (46)
|
0.4698
|
0.1333
|
BioCarta//Hs_Stress Induction of HSP Regulation
|
2/14 (22)
|
0.4644
|
0.1336
|
BioCarta//Hs_B Cell Survival Pathway
|
2/14 (16)
|
0.4644
|
0.1336
|
BioCarta//Hs_Classical Complement Pathway
|
2/14 (68)
|
0.4644
|
0.1336
|
BioCarta//Hs_Protein Kinase A at the Centrosome
|
2/14 (28)
|
0.4644
|
0.1336
|
BioCarta//Hs_Estrogen-responsive protein Efp controls cell cycle and breast tumors growth
|
2/14 (59)
|
0.4644
|
0.1336
|
BioCarta//Hs_TACI and BCMA stimulation of B cell immune responses.
|
2/14 (21)
|
0.4644
|
0.1336
|
BioCarta//Hs_Platelet Amyloid Precursor Protein Pathway
|
2/14 (15)
|
0.4644
|
0.1336
|
BioCarta//Hs_CDK Regulation of DNA Replication
|
1/17 (56)
|
0.8624
|
0.1337
|
BioCarta//Hs_Role of Erk5 in Neuronal Survival
|
1/17 (36)
|
0.8624
|
0.1337
|
BioCarta//Hs_BTG family proteins and cell cycle regulation
|
1/11 (13)
|
0.7222
|
0.1337
|
BioCarta//Hs_Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle
|
1/11 (30)
|
0.7222
|
0.1337
|
BioCarta//Hs_Granzyme A mediated Apoptosis Pathway
|
1/11 (28)
|
0.7222
|
0.1337
|
BioCarta//Hs_Sprouty regulation of tyrosine kinase signals
|
3/18 (31)
|
0.3148
|
0.1340
|
BioCarta//Hs_Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy
|
3/18 (31)
|
0.3148
|
0.1340
|
BioCarta//Hs_Nerve growth factor pathway (NGF)
|
3/18 (38)
|
0.3148
|
0.1340
|
BioCarta//Hs_ADP-Ribosylation Factor
|
3/21 (57)
|
0.4091
|
0.1341
|
BioCarta//Hs_Role of ERBB2 in Signal Transduction and Oncology
|
3/21 (34)
|
0.4091
|
0.1341
|
BioCarta//Hs_Roles of ?arrestin-dependent Recruitment of Src Kinases in GPCR Signaling
|
3/21 (34)
|
0.4091
|
0.1341
|
BioCarta//Hs_Insulin Signaling Pathway
|
3/21 (48)
|
0.4091
|
0.1341
|
BioCarta//Hs_NF-kB Signaling Pathway
|
2/23 (49)
|
0.7367
|
0.1346
|
BioCarta//Hs_CTCF: First Multivalent Nuclear Factor
|
2/23 (26)
|
0.7367
|
0.1346
|
BioCarta//Hs_Ras Signaling Pathway
|
2/22 (23)
|
0.7135
|
0.1346
|
BioCarta//Hs_The 4-1BB-dependent immune response
|
1/18 (22)
|
0.8777
|
0.1350
|
BioCarta//Hs_TNFR2 Signaling Pathway
|
1/18 (32)
|
0.8777
|
0.1350
|
BioCarta//Hs_Inhibition of Huntingtons disease neurodegeneration by histone deacetylase inhibitors
|
1/4 (9)
|
0.3717
|
0.1351
|
BioCarta//Hs_Formation of Ketone Bodies from acetyl-CoA
|
1/4 (4)
|
0.3717
|
0.1351
|
BioCarta//Hs_T Cell Receptor and CD3 Complex
|
1/4 (19)
|
0.3717
|
0.1351
|
BioCarta//Hs_Generation of amyloid b-peptide by PS1
|
1/4 (9)
|
0.3717
|
0.1351
|
BioCarta//Hs_Catabolic Pathways for Methionine, Isoleucine, Threonine and Valine
|
1/4 (4)
|
0.3717
|
0.1351
|
BioCarta//Hs_Basic mechanism of action of PPARa, PPARb(d) and PPARg and effects on gene expression
|
1/4 (7)
|
0.3717
|
0.1351
|
BioCarta//Hs_Basic Mechanisms of SUMOylation
|
1/4 (25)
|
0.3717
|
0.1351
|
BioCarta//Hs_Antigen Dependent B Cell Activation
|
2/10 (24)
|
0.3011
|
0.1353
|
BioCarta//Hs_Free Radical Induced Apoptosis
|
2/10 (11)
|
0.3011
|
0.1353
|
BioCarta//Hs_Neuroregulin receptor degredation protein-1 Controls ErbB3 receptor recycling
|
1/5 (21)
|
0.4407
|
0.1356
|
BioCarta//Hs_Blockade of Neurotransmitter Relase by Botulinum Toxin
|
1/5 (28)
|
0.4407
|
0.1356
|
BioCarta//Hs_Cycling of Ran in nucleocytoplasmic transport
|
1/5 (8)
|
0.4407
|
0.1356
|
BioCarta//Hs_Ion Channel and Phorbal Esters Signaling Pathway
|
1/5 (7)
|
0.4407
|
0.1356
|
BioCarta//Hs_How Progesterone Initiates the Oocyte Maturation
|
4/30 (32)
|
0.4208
|
0.1357
|
BioCarta//Hs_Role of Tob in T-cell activation
|
1/19 (30)
|
0.8912
|
0.1361
|
BioCarta//Hs_Ras-Independent pathway in NK cell-mediated cytotoxicity
|
1/19 (19)
|
0.8912
|
0.1361
|
BioCarta//Hs_CD40L Signaling Pathway
|
2/15 (27)
|
0.5018
|
0.1365
|
BioCarta//Hs_IL 3 signaling pathway
|
2/15 (30)
|
0.5018
|
0.1365
|
BioCarta//Hs_HIV-1 defeats host-mediated resistance by CEM15
|
1/3 (5)
|
0.2942
|
0.1368
|
BioCarta//Hs_Nitrogen-depedent regulation of Rtg1 and Rtg3 in TOR pathway
|
1/3 (8)
|
0.2942
|
0.1368
|
BioCarta//Hs_Biosynthesis of Arginine in Bacteria
|
1/3 (3)
|
0.2942
|
0.1368
|
BioCarta//Hs_Role of MAL in Rho-Mediated Activation of SRF
|
3/19 (26)
|
0.3464
|
0.1372
|
BioCarta//Hs_Ion Channels and Their Functional Role in Vascular Endothelium
|
1/20 (20)
|
0.9033
|
0.1374
|
BioCarta//Hs_G-Protein Signaling Through Tubby Proteins
|
1/7 (11)
|
0.5569
|
0.1375
|
BioCarta//Hs_Regulation of Splicing through Sam68
|
1/7 (8)
|
0.5569
|
0.1375
|
BioCarta//Hs_The reactions that feed amino groups into the urea cycle
|
1/7 (16)
|
0.5569
|
0.1375
|
BioCarta//Hs_Melanocyte Development and Pigmentation Pathway
|
1/7 (13)
|
0.5569
|
0.1375
|
BioCarta//Hs_The role of FYVE-finger proteins in vesicle transport
|
1/7 (35)
|
0.5569
|
0.1375
|
BioCarta//Hs_TGF beta signaling pathway
|
2/19 (76)
|
0.6336
|
0.1377
|
BioCarta//Hs_Complement Pathway
|
2/19 (33)
|
0.6336
|
0.1377
|
BioCarta//Hs_ChREBP regulation by carbohydrates and cAMP
|
2/19 (30)
|
0.6336
|
0.1377
|
BioCarta//Hs_Lissencephaly gene (LIS1) in neuronal migration and development
|
2/19 (48)
|
0.6336
|
0.1377
|
BioCarta//Hs_Role of PPAR-gamma Coactivators in Obesity and Thermogenesis
|
2/9 (12)
|
0.2583
|
0.1378
|
BioCarta//Hs_HIV Induced T Cell Apoptosis
|
2/9 (23)
|
0.2583
|
0.1378
|
BioCarta//Hs_Lck and Fyn tyrosine kinases in initiation of TCR Activation
|
2/9 (16)
|
0.2583
|
0.1378
|
BioCarta//Hs_GATA3 participate in activating the Th2 cytokine genes expression
|
2/16 (25)
|
0.5374
|
0.1378
|
BioCarta//Hs_Sonic Hedgehog (Shh) Pathway
|
2/16 (29)
|
0.5374
|
0.1378
|
BioCarta//Hs_Cell Cycle: G1/S Check Point
|
3/28 (34)
|
0.6075
|
0.1381
|
BioCarta//Hs_Caspase Cascade in Apoptosis
|
1/22 (27)
|
0.9236
|
0.1384
|
BioCarta//Hs_Dendritic cells in regulating TH1 and TH2 Development
|
1/22 (25)
|
0.9236
|
0.1384
|
BioCarta//Hs_Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia
|
1/22 (40)
|
0.9236
|
0.1384
|
BioCarta//Hs_Cytokine Network
|
1/22 (103)
|
0.9236
|
0.1384
|
BioCarta//Hs_NO2-dependent IL 12 Pathway in NK cells
|
2/17 (20)
|
0.5713
|
0.1385
|
BioCarta//Hs_Cells and Molecules involved in local acute inflammatory response
|
2/17 (19)
|
0.5713
|
0.1385
|
BioCarta//Hs_Cell Cycle: G2/M Checkpoint
|
3/24 (27)
|
0.4992
|
0.1387
|
BioCarta//Hs_Activation of Src by Protein-tyrosine phosphatase alpha
|
2/11 (29)
|
0.3435
|
0.1388
|
BioCarta//Hs_Vitamin C in the Brain
|
2/11 (20)
|
0.3435
|
0.1388
|
BioCarta//Hs_AKAP95 role in mitosis and chromosome dynamics
|
2/11 (39)
|
0.3435
|
0.1388
|
BioCarta//Hs_Phospholipase C Signaling Pathway
|
2/8 (12)
|
0.2156
|
0.1391
|
BioCarta//Hs_RNA polymerase III transcription
|
2/8 (22)
|
0.2156
|
0.1391
|
BioCarta//Hs_Internal Ribosome entry pathway
|
2/8 (39)
|
0.2156
|
0.1391
|
BioCarta//Hs_Phosphoinositides and their downstream targets.
|
1/23 (23)
|
0.9321
|
0.1391
|
BioCarta//Hs_Trefoil Factors Initiate Mucosal Healing
|
1/24 (95)
|
0.9396
|
0.1392
|
BioCarta//Hs_NFkB activation by Nontypeable Hemophilus influenzae
|
1/24 (43)
|
0.9396
|
0.1392
|
BioCarta//Hs_IL 5 Signaling Pathway
|
1/8 (19)
|
0.6057
|
0.1392
|
BioCarta//Hs_Antigen Processing and Presentation
|
1/8 (16)
|
0.6057
|
0.1392
|
BioCarta//Hs_Shuttle for transfer of acetyl groups from mitochondria to the cytosol
|
1/8 (11)
|
0.6057
|
0.1392
|
BioCarta//Hs_The Citric Acid Cycle
|
1/8 (9)
|
0.6057
|
0.1392
|
BioCarta//Hs_Stat3 Signaling Pathway
|
1/8 (13)
|
0.6057
|
0.1392
|
BioCarta//Hs_TNF/Stress Related Signaling
|
1/25 (31)
|
0.9463
|
0.1397
|
BioCarta//Hs_Regulation of ck1/cdk5 by type 1 glutamate receptors
|
3/17 (38)
|
0.2833
|
0.1399
|
BioCarta//Hs_uCalpain and friends in Cell spread
|
3/17 (36)
|
0.2833
|
0.1399
|
BioCarta//Hs_Y branching of actin filaments
|
3/17 (45)
|
0.2833
|
0.1399
|
BioCarta//Hs_Influence of Ras and Rho proteins on G1 to S Transition
|
1/26 (33)
|
0.9523
|
0.1400
|
BioCarta//Hs_TNFR1 Signaling Pathway
|
3/29 (36)
|
0.6320
|
0.1412
|
BioCarta//Hs_METS affect on Macrophage Differentiation
|
3/16 (30)
|
0.2521
|
0.1420
|
BioCarta//Hs_p53 Signaling Pathway
|
3/16 (27)
|
0.2521
|
0.1420
|
BioCarta//Hs_Signal transduction through IL1R
|
1/30 (41)
|
0.9703
|
0.1422
|
BioCarta//Hs_IL22 Soluble Receptor Signaling Pathway
|
3/12 (40)
|
0.1358
|
0.1429
|
BioCarta//Hs_T Helper Cell Surface Molecules
|
3/12 (12)
|
0.1358
|
0.1429
|
BioCarta//Hs_T Cytotoxic Cell Surface Molecules
|
3/12 (12)
|
0.1358
|
0.1429
|
BioCarta//Hs_Phospholipase C-epsilon pathway
|
3/12 (25)
|
0.1358
|
0.1429
|
BioCarta//Hs_How does salmonella hijack a cell
|
3/12 (32)
|
0.1358
|
0.1429
|
BioCarta//Hs_Tumor Suppressor Arf Inhibits Ribosomal Biogenesis
|
3/12 (17)
|
0.1358
|
0.1429
|
BioCarta//Hs_Th1/Th2 Differentiation
|
2/18 (88)
|
0.6034
|
0.1437
|
BioCarta//Hs_Mechanisms of transcriptionalrepression by DNA methylation
|
3/14 (20)
|
0.1916
|
0.1474
|
BioCarta//Hs_Inhibition of Cellular Proliferation by Gleevec
|
4/22 (23)
|
0.2148
|
0.1481
|
BioCarta//Hs_mCalpain and friends in Cell motility
|
4/22 (38)
|
0.2148
|
0.1481
|
BioCarta//Hs_Role of Mitochondria in Apoptotic Signaling
|
4/20 (38)
|
0.1681
|
0.1494
|
BioCarta//Hs_Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor
|
4/20 (24)
|
0.1681
|
0.1494
|
BioCarta//Hs_Phosphatidylcholine Biosynthesis Pathway
|
1/2 (2)
|
0.2072
|
0.1507
|
BioCarta//Hs_Biosynthesis of Cysteine in mammals
|
1/2 (2)
|
0.2072
|
0.1507
|
BioCarta//Hs_Nitric Oxide Signaling Pathway
|
4/21 (25)
|
0.1910
|
0.1528
|
BioCarta//Hs_Thrombin signaling and protease-activated receptors
|
4/21 (31)
|
0.1910
|
0.1528
|
BioCarta//Hs_CBL mediated ligand-induced downregulation of EGF receptors
|
3/13 (51)
|
0.1630
|
0.1552
|
BioCarta//Hs_Transcription Regulation by Methyltransferase of CARM1
|
3/13 (34)
|
0.1630
|
0.1552
|
BioCarta//Hs_Attenuation of GPCR Signaling
|
3/13 (13)
|
0.1630
|
0.1552
|
BioCarta//Hs_TSP-1 Induced Apoptosis in Microvascular Endothelial Cell
|
2/6 (9)
|
0.1333
|
0.1720
|
BioCarta//Hs_Mechanism of Acetaminophen Activity and Toxicity
|
2/6 (7)
|
0.1333
|
0.1720
|
BioCarta//Hs_Bystander B Cell Activation
|
2/6 (15)
|
0.1333
|
0.1720
|
BioCarta//Hs_Metabolism of Anandamide, an Endogenous Cannabinoid
|
2/6 (13)
|
0.1333
|
0.1720
|
BioCarta//Hs_Beta-Oxidation of Fatty Acids
|
2/6 (6)
|
0.1333
|
0.1720
|
BioCarta//Hs_Prion Pathway
|
3/11 (11)
|
0.1103
|
0.1839
|
BioCarta//Hs_Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation
|
3/11 (35)
|
0.1103
|
0.1839
|
BioCarta//Hs_Erythropoietin mediated neuroprotection through NF-kB
|
3/11 (17)
|
0.1103
|
0.1839
|
BioCarta//Hs_Regulators of Bone Mineralization
|
3/10 (57)
|
0.0870
|
0.1933
|
BioCarta//Hs_IL 17 Signaling Pathway
|
4/15 (16)
|
0.0724
|
0.2069
|
BioCarta//Hs_Anthrax Toxin Mechanism of Action
|
2/2 (2)
|
0.0119
|
0.4778
|